MAR
50
3
CRM
50
-5
SLG
66
4
PSX
42
3
AEE
61
-2
MCK
46
-3
TRIP
60
3
GOOGL
53
2
ECL
69
-3
TDC
47
-2
VRSK
35
-3
INTU
60
-3
TAP
51
-2
EXPE
74
2
AVB
65
-2
ADSK
65
-2
LYB
44
-2
HBI
59
-2
CCL
71
4
PYPL
45
-2
MAR
50
3
CRM
50
-5
SLG
66
4
PSX
42
3
AEE
61
-2
MCK
46
-3
TRIP
60
3
GOOGL
53
2
ECL
69
-3
TDC
47
-2
VRSK
35
-3
INTU
60
-3
TAP
51
-2
EXPE
74
2
AVB
65
-2
ADSK
65
-2
LYB
44
-2
HBI
59
-2
CCL
71
4
PYPL
45
-2
Financhill
Back

TG Therapeutics Quote, Financials, Valuation and Earnings

"EarnPhone": The Investment Hidden in Plain Sight

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
65

TGTX
TG Therapeutics

Last Price:
25.24
Seasonality Move:
-11.23%

7 Day Trial

ALL ACCESS PASS

$ 7

"The Next Apple?" - Mode's Growth Story is Turning Heads

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

TG Therapeutics Price Quote

$25.24
-0.01 (0.64%)
(Updated: September 19, 2024 at 6:19 AM ET)

TG Therapeutics Key Stats

Buy
65
TG Therapeutics (TGTX) is a Buy
Day range:
$25.06 - $26.41
52-week range:
$6.46 - $26.41
Dividend yield:
0%
P/E ratio:
280.56
P/S ratio:
11.25
P/B ratio:
22.02%
Volume:
4M
Avg. volume:
3.5M
1-year change:
165.51%
Market cap:
$3.9B
Revenue:
$233.7M
EPS:
$0.6

How Much Does TG Therapeutics Make?

Is TG Therapeutics Growing As A Company?

  • What Is TG Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 3.57%
  • What Is TG Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

TG Therapeutics Stock Price Performance

  • Did TG Therapeutics Stock Go Up Last Month?
    TG Therapeutics share price went up by 14.36% last month
  • Did TGTX's Share Price Rise Over The Last Year?
    TGTX share price rose by 165.51% over the past 1 year

What Is TG Therapeutics 52-Week High & Low?

TG Therapeutics Price To Free Cash Flow

Is It Risky To Buy TG Therapeutics?

  • How Much Debt Does TG Therapeutics Have?
    Total long term debt quarterly is $102.5M
  • How Much Cash Does TG Therapeutics Have?
    Cash and short term investments quarterly total is $217.3M
  • What Is TG Therapeutics’s Book Value Per Share?
    Book value per share is 1.15

Is TG Therapeutics Cash Flow Positive?

  • What Is TGTX Cash Flow From Operations?
    Cash flow from operations (TTM) is $67.8M
  • What Is TG Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $565K
  • What Is TG Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$82.5M

TG Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    TGTX return on invested capital is 39.74%
  • What Is TG Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 28.89%
  • What Is TGTX Return On Equity?
    ROE is a measure of profitability and is 68.02%

TG Therapeutics Earnings Date & Stock Price

TG Therapeutics Competitors

  • Who Are TG Therapeutics's Competitors?
    Below is a list of companies who compete with TG Therapeutics or are related in some way:
    • ADMA Biologics Inc (ADMA)
    • AdaptHealth Corp (AHCO)
    • Inspire Medical Systems Inc (INSP)
    • Mirum Pharmaceuticals Inc (MIRM)
    • Varex Imaging Corp (VREX)

TG Therapeutics Dividend Yield

TG Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 209.44%
Revenue: 357.05% 11.49%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 33.75
Upside from Last Price: 33.66%

Major Shareholders

  • How many TGTX shares are owned by institutional investors?
    129.9M TGTX shares are owned by institutional investors
  • How many TGTX shares are owned by insiders?
    22.1M TGTX shares are owned by insiders